CB Rank (Investor) 270,056
  • Gender Male

Troy is an experienced and passionate Biotechnology Entrepreneur with a track record of successful start-ups and consultancy in Australia and abroad. Prior to starting Xeophin, Troy was the CEO and Co-founder of Sementis Ltd, a successful Australian Biotech specialising in gene therapies for allergies and infectious disease. His strengths lie in

establishing collaborations and ‘deals’ in the Biotech and Pharmaceutical space. His engineering background can be seen in his methodical and detail orientated approach to technical collaborations and transactional work. Prior to his decade of Biotech Executive and Directorial roles, Troy has consulted to Australian and International companies such as Tenix, Energex, Parsons Brinckerhoff and Worley Parsons, and led multisite teams across continents. Troy is currently studying for an MBA with Griffith University.

Number of Current Jobs 1
Troy Neilson is the CEO at Xeophin.
There is no recent news or activity for this profile.